Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Kurt Neeser"'
Autor:
Regina Munter-Young, Adolfo Fuentes-Alburo, Nicholas DiGregorio, Kurt Neeser, Dmitry Gultyaev
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0302486 (2024)
Background and objectivesCorrect identification of estrogen receptor (ER) status in breast cancer (BC) is crucial to optimize treatment; however, standard of care, involving biopsy and immunohistochemistry (IHC), and other diagnostic tools such as 2-
Externí odkaz:
https://doaj.org/article/ffe78734fd1a4b42a6f1d207a4fd13f3
Autor:
Bilal Chughtai, Sirikan Rojanasarot, Kurt Neeser, Dmitry Gultyaev, Shuai Fu, Samir K. Bhattacharyya, Ahmad M. El-Arabi, Ben J. Cutone, Kevin T. McVary
Publikováno v:
PLoS ONE, Vol 17, Iss 4 (2022)
Treatment options for men with moderate-to-severe lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) have variable efficacy, safety, and retreatment profiles, contributing to variations in patient quality of life and health
Externí odkaz:
https://doaj.org/article/0a37290c734741a79f88c6dbed82b69f
Autor:
Bilal Chughtai, Sirikan Rojanasarot, Kurt Neeser, Dmitry Gultyaev, Stacey L. Amorosi, Neal D. Shore
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 8, Iss 1 (2021)
**Background:** Benign prostatic hyperplasia (BPH) is one of the most prevalent and costly chronic conditions among middle-aged and elderly men. Prostatic urethral lift (PUL) and convective water vapor thermal therapy (WVTT) are emerging minimally in
Externí odkaz:
https://doaj.org/article/8361c207367c43c19116d714866f036c
Autor:
Alexander Kypta, Hermann Blessberger, Juergen Kammler, Alexander Nahler, Kurt Neeser, Michael Lichtenauer, Christoph Edlinger, Joerg Kellermair, Daniel Kiblboeck, Thomas Lambert, Johannes Auer, Clemens Steinwender
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0192587 (2018)
Intra-operative complications like mechanical damages to the leads, infections and hematomas during generator replacements of implantable pacemakers and defibrillators contribute to additional costs for hospitals. The aim of this study was to evaluat
Externí odkaz:
https://doaj.org/article/d85dbe7c65ea428abc6237a12c25a79b
Publikováno v:
International Journal of Technology Assessment in Health Care. 38:S8-S9
IntroductionTreatment options for men with moderate-to-severe lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) include medical therapy, minimally invasive surgical therapies (MISTs), and invasive surgical procedures. While these
Publikováno v:
International Journal of Technology Assessment in Health Care. 38:S94-S94
IntroductionDiagnostic testing and patient monitoring are important to diagnose potential diseases and to evaluate treatment regimens. Since diagnosis and treatment monitoring have no intrinsic effects, an economic evaluation of biomarkers is inevita
Publikováno v:
Journal of Comparative Effectiveness Research. 8:577-587
Aim: To estimate financial implications of adopting niraparib as maintenance treatment in recurrent ovarian cancer. Materials & methods: A model was developed to estimate the budget impact of treating patients with niraparib compared with alternative
Publikováno v:
Journal of Diabetes Science and Technology
The modeling approach described here is designed to support the development of spreadsheet-based simple predictive models. It is based on 3 pillars: association of the complications with HbA1c changes, incidence of the complications, and average cost
Autor:
Michael Lichtenauer, Juergen Kammler, Clemens Steinwender, Alexander Nahler, Christoph Edlinger, Joerg Kellermair, Alexander Kypta, Kurt Neeser, Thomas Lambert, Johannes Auer, Hermann Blessberger, Daniel Kiblboeck
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0192587 (2018)
PLoS ONE
PLoS ONE
Introduction Intra-operative complications like mechanical damages to the leads, infections and hematomas during generator replacements of implantable pacemakers and defibrillators contribute to additional costs for hospitals. The aim of this study w
Publikováno v:
International Journal of Technology Assessment in Health Care. 35:40-41
IntroductionIn 2011 the Arzneimittelmarkt-Neuordnungsgesetz (AMNOG) evaluation process for new drugs was implemented in Germany. Since then, the evidence requirements follow high standards and results impact reimbursement price negotiations. More rec